CancerVax Corporation (NASDAQ: CNVX), a biotechnology company focused on the research, development and commercialization of novel biological products for the treatment of cancer, announced today that David F. Hale, President and Chief Executive Officer of CancerVax Corporation, will present at SG Cowen's 26th Annual Health Care Conference on Tuesday, March 7, 2006 at 3:10pm. Eastern Standard Time (EST) at the Boston Marriott Copley Place in Boston, Massachusetts. Joining Mr. Hale will be Christian Itin, PhD, CEO of Micromet AG. Mr. Hale and Dr. Itin will provide an overview of CancerVax's proposed merger with Micromet AG, and an update on the development status of the Companies' product candidates.
